Abstract
Hyaluronan (HA) is a highly biocompatible biopolymer that is widely used for a variety of therapeutic purposes including surgical preparations, adhesion prevention, viscosupplementation and drug and cytokine delivery. Delivery can be accomplished effectively when HA-based carriers are synthesized in the form of hydrogels, though doing so normally requires chemical modification of the native HA structure. Solute delivery from HA-based gels can be either “simple”, that is from a gel not including separate components intended to control release, or “regulated” when specific components are included for that purpose. A variety of modified forms of HA have been developed and used for delivery of desired molecules in therapeutic, clinical, veterinary and laboratory research environments, and the number of such applications is likely to grow in future years.
Keywords: Hyaluronan, hydrogels, cytokines, growth factors, biomaterials.
Current Pharmaceutical Biotechnology
Title:Release of Growth Factors, Cytokines and Therapeutic Molecules by Hyaluronan-based Hydrogels
Volume: 13 Issue: 7
Author(s): Robert A. Peattie
Affiliation:
Keywords: Hyaluronan, hydrogels, cytokines, growth factors, biomaterials.
Abstract: Hyaluronan (HA) is a highly biocompatible biopolymer that is widely used for a variety of therapeutic purposes including surgical preparations, adhesion prevention, viscosupplementation and drug and cytokine delivery. Delivery can be accomplished effectively when HA-based carriers are synthesized in the form of hydrogels, though doing so normally requires chemical modification of the native HA structure. Solute delivery from HA-based gels can be either “simple”, that is from a gel not including separate components intended to control release, or “regulated” when specific components are included for that purpose. A variety of modified forms of HA have been developed and used for delivery of desired molecules in therapeutic, clinical, veterinary and laboratory research environments, and the number of such applications is likely to grow in future years.
Export Options
About this article
Cite this article as:
A. Peattie Robert, Release of Growth Factors, Cytokines and Therapeutic Molecules by Hyaluronan-based Hydrogels, Current Pharmaceutical Biotechnology 2012; 13 (7) . https://dx.doi.org/10.2174/138920112800624427
DOI https://dx.doi.org/10.2174/138920112800624427 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Prodigiosins as Anti Cancer Agents: Living Upto Their Name
Current Pharmaceutical Design The Long Term Biological Consequences of Anorexia Nervosa
Current Nutrition & Food Science Psychological Stress and Puerperal Mastitis - Possible Pathophysiological Mechanisms
Current Women`s Health Reviews Gene Expression-Based Pharmacodynamic Biomarkers: The Beginning of a New Era in Biomarker-Driven Anti-Tumor Drug Development
Current Molecular Medicine Meet Our Associate Editors
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Reshaping the Protein Folding Pathway by Osmolyte via its Effects on the Folding Intermediates
Current Protein & Peptide Science Infectious Complications with Anti-TNFα Therapy in Rheumatic Diseases: A Review
Recent Patents on Inflammation & Allergy Drug Discovery Melatonin and Its Therapeutic Potential in Neuroprotection
Central Nervous System Agents in Medicinal Chemistry Mesenchymal Stem Cells: Promising for Myocardial Regeneration?
Current Stem Cell Research & Therapy The Need for Calcium Channels in Cell Proliferation
Recent Patents on Anti-Cancer Drug Discovery Update on the Medical Treatment of Allergic Rhinitis
Inflammation & Allergy - Drug Targets (Discontinued) The Role of PEDF in Tumor Growth and Metastasis
Current Molecular Medicine Topical Use of Sucralfate in Epithelial Wound Healing: Clinical Evidence and Molecular Mechanisms of Action
Recent Patents on Inflammation & Allergy Drug Discovery Identification of Two Novel Mutations in the <i>ATM</i> Gene from Patients with Ataxia-Telangiectasia by Whole Exome Sequencing
Current Genomics Heparin Derivatives as Angiogenesis Inhibitors
Current Pharmaceutical Design A Progressive Review of V600E-B-RAF-Dependent Melanoma and Drugs Inhibiting It
Mini-Reviews in Medicinal Chemistry HLA-DR: Molecular Insights and Vaccine Design
Current Pharmaceutical Design Small Interfering RNAs and Antisense Oligonucleotides for Treatment of Neurological Diseases
Current Drug Targets Kinetics and Docking Studies of a COX-2 Inhibitor Isolated from Terminalia bellerica Fruits
Protein & Peptide Letters Xanthine Oxidase Inhibitor Febuxostat as a Novel Agent Postulated to Act Against Vascular Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry